Treating Critically Ill Patients Experiencing SARS-CoV-2 Severe Infection with Ig-M and Ig-A Enriched Ig-G Infusion

Treating Critically Ill Patients Experiencing SARS-CoV-2 Severe Infection with Ig-M and Ig-A Enriched Ig-G Infusion

SARS-CoV-2 in patients who need intensive care unit (ICU) is associated with a mortality rate ranging from 10 to 40–45%, with an increase in morbidity and mortality in presence of sepsis. We hypothesized that IgM and IgA enriched immunoglobulin G may support the sepsis-related phase improving patien...

Full description

Bibliographic Details
Main Authors: Alberto Corona, Giuseppe Richini, Sara Simoncini, Marta Zangrandi, Monica Biasini, Giuseppe Russo, Mauro Pasqua, Clemente Santorsola, Camilla Gregorini, Chiara Giordano
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Antibiotics
Subjects:
COVID-19
critically ill patients
secondary bacterial infection
co-infection
Online Access:https://www.mdpi.com/2079-6382/10/8/930

Internet

https://www.mdpi.com/2079-6382/10/8/930

Similar Items